Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masafumi Endo

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Scientific Reports|February 18, 2026
Deep probabilistic traversability with test-time adaptation for uncertainty-aware planetary rover navigationMasafumi Endo, Tatsunori Taniai, Genya Ishigami
Current HIV Research|February 22, 2008
Human immunodeficiency virus-induced apoptosis of human breast cancer cells via CXCR4 is mediated by the viral envelope protein but does not require CD4Masafumi Endo, Asako Inatsu, Koji Hashimoto, et al.
Biological & Pharmaceutical Bulletin|November 5, 2010
Treatment of breast cancer cells with proteasome inhibitor lactacystin increases the level of sensitivity to cell death induced by human immunodeficiency virus type 1Masafumi Endo, Shouichirou Gejima, Asako Endo, et al.
Npj Viruses|April 28, 2025
An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamstersRyuta Uraki, Mutsumi Ito, Maki Kiso, et al.
The Journal of Biological Chemistry|May 29, 2003
A novel cyclic peptide immunization strategy for preventing HIV-1/AIDS infection and progressionShogo Misumi, Masafumi Endo, Ryouzaburou Mukai, et al.
Influenza and Other Respiratory Viruses|June 25, 2020
Clinical phase II and III studies of an AS03-adjuvanted H5N1 influenza vaccine produced in an EB66<sup>®</sup> cell culture platformMasafumi Endo, Mitsuyoshi Tanishima, Kayo Ibaragi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
Effects of immunization with CCR5-based cycloimmunogen on simian/HIVSF162P3 challengeShogo Misumi, Daisuke Nakayama, Masashi Kusaba, et al.
Vaccine|December 16, 2022
Assessing the pyrogenicity of whole influenza virus particle vaccine in cynomolgus macaquesMarumi Ohno, Masataka Sagata, Toshiki Sekiya, et al.
Scientific Reports|February 20, 2024
Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccineChimuka Handabile, Marumi Ohno, Toshiki Sekiya, et al.
Vaccine|March 13, 2019
Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenzaToshiki Sekiya, Edin J Mifsud, Marumi Ohno, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Scientific Reports|February 18, 2026
Deep probabilistic traversability with test-time adaptation for uncertainty-aware planetary rover navigationMasafumi Endo, Tatsunori Taniai, Genya Ishigami
Current HIV Research|February 22, 2008
Human immunodeficiency virus-induced apoptosis of human breast cancer cells via CXCR4 is mediated by the viral envelope protein but does not require CD4Masafumi Endo, Asako Inatsu, Koji Hashimoto, et al.
Biological & Pharmaceutical Bulletin|November 5, 2010
Treatment of breast cancer cells with proteasome inhibitor lactacystin increases the level of sensitivity to cell death induced by human immunodeficiency virus type 1Masafumi Endo, Shouichirou Gejima, Asako Endo, et al.
Npj Viruses|April 28, 2025
An XBB.1.5-based inactivated SARS-CoV-2 vaccine partially protects against XBB.1.5 and JN.1 strains in hamstersRyuta Uraki, Mutsumi Ito, Maki Kiso, et al.
The Journal of Biological Chemistry|May 29, 2003
A novel cyclic peptide immunization strategy for preventing HIV-1/AIDS infection and progressionShogo Misumi, Masafumi Endo, Ryouzaburou Mukai, et al.
Influenza and Other Respiratory Viruses|June 25, 2020
Clinical phase II and III studies of an AS03-adjuvanted H5N1 influenza vaccine produced in an EB66<sup>®</sup> cell culture platformMasafumi Endo, Mitsuyoshi Tanishima, Kayo Ibaragi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2005
Effects of immunization with CCR5-based cycloimmunogen on simian/HIVSF162P3 challengeShogo Misumi, Daisuke Nakayama, Masashi Kusaba, et al.
Vaccine|December 16, 2022
Assessing the pyrogenicity of whole influenza virus particle vaccine in cynomolgus macaquesMarumi Ohno, Masataka Sagata, Toshiki Sekiya, et al.
Scientific Reports|February 20, 2024
Immunogenicity and protective efficacy of a co-formulated two-in-one inactivated whole virus particle COVID-19/influenza vaccineChimuka Handabile, Marumi Ohno, Toshiki Sekiya, et al.
Vaccine|March 13, 2019
Inactivated whole virus particle vaccine with potent immunogenicity and limited IL-6 induction is ideal for influenzaToshiki Sekiya, Edin J Mifsud, Marumi Ohno, et al.
Pageof 2